Runzhe Chen

2.8k total citations
40 papers, 502 citations indexed

About

Runzhe Chen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Runzhe Chen has authored 40 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 10 papers in Hematology. Recurrent topics in Runzhe Chen's work include Cancer Immunotherapy and Biomarkers (9 papers), Multiple Myeloma Research and Treatments (5 papers) and CAR-T cell therapy research (5 papers). Runzhe Chen is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Multiple Myeloma Research and Treatments (5 papers) and CAR-T cell therapy research (5 papers). Runzhe Chen collaborates with scholars based in China, United States and Australia. Runzhe Chen's co-authors include Baoan Chen, Baoan Chen, Hongming Zhang, Baoan Chen, Ye Li, Chengxin Luan, Xiang Yan, Yi Hu, Zhibo Zhang and Jinliang Wang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Runzhe Chen

37 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Runzhe Chen China 14 241 144 122 85 71 40 502
Domenico Ciliberto Italy 14 415 1.7× 219 1.5× 130 1.1× 68 0.8× 88 1.2× 30 672
Shilpa Lingala United States 10 170 0.7× 264 1.8× 93 0.8× 59 0.7× 70 1.0× 19 920
Darlene Gibbon United States 15 325 1.3× 375 2.6× 115 0.9× 53 0.6× 55 0.8× 38 834
Mark DeMario United States 14 402 1.7× 437 3.0× 102 0.8× 50 0.6× 82 1.2× 25 809
Khalil Choucair United States 12 234 1.0× 337 2.3× 178 1.5× 108 1.3× 82 1.2× 36 693
Ziqiang Zhu China 13 182 0.8× 281 2.0× 77 0.6× 153 1.8× 32 0.5× 31 609
Guy Rosner Israel 13 220 0.9× 155 1.1× 97 0.8× 28 0.3× 56 0.8× 24 587
Muxin Yu China 15 175 0.7× 211 1.5× 82 0.7× 322 3.8× 48 0.7× 31 697
Whitney P. Kirschbrown United States 10 214 0.9× 111 0.8× 107 0.9× 53 0.6× 29 0.4× 16 416
Vince D. Cataldo United States 8 208 0.9× 200 1.4× 210 1.7× 56 0.7× 21 0.3× 17 520

Countries citing papers authored by Runzhe Chen

Since Specialization
Citations

This map shows the geographic impact of Runzhe Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Runzhe Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Runzhe Chen more than expected).

Fields of papers citing papers by Runzhe Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Runzhe Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Runzhe Chen. The network helps show where Runzhe Chen may publish in the future.

Co-authorship network of co-authors of Runzhe Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Runzhe Chen. A scholar is included among the top collaborators of Runzhe Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Runzhe Chen. Runzhe Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Runzhe, Qi Quan, D. S. Shen, et al.. (2025). Radiographic ground-glass nodules predict less aggressive features and favorable immune landscapes in early lung adenocarcinoma and its precursors. Translational Lung Cancer Research. 14(6). 2089–2099.
2.
3.
Altan, Mehmet, Ziyi Li, Runzhe Chen, et al.. (2024). High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastatic NSCLC. Journal for ImmunoTherapy of Cancer. 12(12). e008950–e008950. 5 indexed citations
4.
5.
Zhang, Yanxi, et al.. (2023). Fault Diagnosis of Aviation Secondary Power Supply Based on SVM. 35. 1–5.
6.
Chen, Runzhe, Xuan Zhu, Wenqing Wang, et al.. (2023). Comparison of stereotactic body radiation therapy versus surgery for multiple primary lung cancers after prior radical resection: A multicenter retrospective study. Clinical and Translational Radiation Oncology. 40. 100601–100601. 4 indexed citations
7.
Guo, Ying, et al.. (2023). Treatment options for stage III-N2 pulmonary lymphoepithelioma-like carcinoma: A retrospective cohort study. Radiotherapy and Oncology. 189. 109937–109937. 2 indexed citations
8.
Guan, Xiaoqing, Zhiyuan Xu, Runzhe Chen, Jiang‐Jiang Qin, & Xiangdong Cheng. (2021). Identification of an Immune Gene-Associated Prognostic Signature and Its Association With a Poor Prognosis in Gastric Cancer Patients. Frontiers in Oncology. 10. 629909–629909. 15 indexed citations
9.
10.
Zhang, Hongming, et al.. (2020). Expression of the SAR2-Cov-2 receptor ACE2 reveals the susceptibility of COVID-19 in non-small cell lung cancer. Journal of Cancer. 11(18). 5289–5292. 26 indexed citations
11.
Li, Yubin, Runzhe Chen, Jian Yang, et al.. (2020). Integrated Bioinformatics Analysis Reveals Key Candidate Genes and Pathways Associated With Clinical Outcome in Hepatocellular Carcinoma. Frontiers in Genetics. 11. 814–814. 16 indexed citations
12.
Zhang, Zhibo, Yuan Fang, Runzhe Chen, et al.. (2020). Dynamics of Serum Tumor Markers Can Serve as a Prognostic Biomarker for Chinese Advanced Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors. Frontiers in Immunology. 11. 1173–1173. 33 indexed citations
13.
14.
Chen, Runzhe, Hongming Zhang, Ping Liu, Xuefeng Wu, & Baoan Chen. (2017). Gambogenic acid synergistically potentiates bortezomib-induced apoptosis in multiple myeloma. Journal of Cancer. 8(5). 839–851. 24 indexed citations
15.
Chen, Baoan & Runzhe Chen. (2015). The role of dasatinib in the management of chronic myeloid leukemia. Drug Design Development and Therapy. 9. 773–773. 55 indexed citations
16.
Chen, Baoan, Hongming Zhang, Runzhe Chen, Jian Cheng, & Nan Jin. (2015). Systematic review and meta-analysis of prospective studies for ECP treatment in patients with steroid-refractory acute GVHD. Patient Preference and Adherence. 9. 105–105. 28 indexed citations
17.
Chen, Baoan & Runzhe Chen. (2015). Siltuximab (CNTO 328): a promising option for human malignancies. Drug Design Development and Therapy. 9. 3455–3455. 50 indexed citations
18.
Chen, Baoan, et al.. (2015). Primary malignant lymphoma of the uterus and broad ligament: a case report and review of literature. OncoTargets and Therapy. 8. 265–265. 13 indexed citations
19.
Chen, Baoan, Runzhe Chen, & Jos L. Campbell. (2015). Prophylaxis and treatment of acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation. OncoTargets and Therapy. 8. 405–405. 7 indexed citations
20.
Chen, Baoan & Runzhe Chen. (2015). Brentuximab vedotin for relapsed or refractory Hodgkin’s lymphoma. Drug Design Development and Therapy. 9. 1729–1729. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Domenico Ciliberto Breakdown of academic impact, for papers by Shilpa Lingala Breakdown of academic impact, for papers by Darlene Gibbon Breakdown of academic impact, for papers by Mark DeMario Breakdown of academic impact, for papers by Khalil Choucair Breakdown of academic impact, for papers by Ziqiang Zhu Breakdown of academic impact, for papers by Guy Rosner Breakdown of academic impact, for papers by Muxin Yu Breakdown of academic impact, for papers by Whitney P. Kirschbrown Breakdown of academic impact, for papers by Vince D. Cataldo
Rankless by CCL
2026